Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
10 2023
Historique:
medline: 26 9 2023
pubmed: 29 10 2022
entrez: 28 10 2022
Statut: ppublish

Résumé

Child maltreatment (CM) and migrant status are independently associated with psychosis. We examined prevalence of CM by migrant status and tested whether migrant status moderated the association between CM and first-episode psychosis (FEP). We further explored whether differences in CM exposure contributed to variations in the incidence rates of FEP by migrant status. We included FEP patients aged 18-64 years in 14 European sites and recruited controls representative of the local populations. Migrant status was operationalized according to generation (first/further) and region of origin (Western/non-Western countries). The reference population was composed by individuals of host country's ethnicity. CM was assessed with Childhood Trauma Questionnaire. Prevalence ratios of CM were estimated using Poisson regression. We examined the moderation effect of migrant status on the odds of FEP by CM fitting adjusted logistic regressions with interaction terms. Finally, we calculated the population attributable fractions (PAFs) for CM by migrant status. We examined 849 FEP cases and 1142 controls. CM prevalence was higher among migrants, their descendants and migrants of non-Western heritage. Migrant status, classified by generation (likelihood test ratio:χ The higher exposure to CM, despite a smaller effect on the odds of FEP, accounted for a greater proportion of incident FEP cases among migrants. Policies aimed at reducing CM should consider the increased vulnerability of specific subpopulations.

Sections du résumé

BACKGROUND
Child maltreatment (CM) and migrant status are independently associated with psychosis. We examined prevalence of CM by migrant status and tested whether migrant status moderated the association between CM and first-episode psychosis (FEP). We further explored whether differences in CM exposure contributed to variations in the incidence rates of FEP by migrant status.
METHODS
We included FEP patients aged 18-64 years in 14 European sites and recruited controls representative of the local populations. Migrant status was operationalized according to generation (first/further) and region of origin (Western/non-Western countries). The reference population was composed by individuals of host country's ethnicity. CM was assessed with Childhood Trauma Questionnaire. Prevalence ratios of CM were estimated using Poisson regression. We examined the moderation effect of migrant status on the odds of FEP by CM fitting adjusted logistic regressions with interaction terms. Finally, we calculated the population attributable fractions (PAFs) for CM by migrant status.
RESULTS
We examined 849 FEP cases and 1142 controls. CM prevalence was higher among migrants, their descendants and migrants of non-Western heritage. Migrant status, classified by generation (likelihood test ratio:χ
CONCLUSIONS
The higher exposure to CM, despite a smaller effect on the odds of FEP, accounted for a greater proportion of incident FEP cases among migrants. Policies aimed at reducing CM should consider the increased vulnerability of specific subpopulations.

Identifiants

pubmed: 36305570
doi: 10.1017/S003329172200335X
pii: S003329172200335X
pmc: PMC10520604
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6150-6160

Références

Schizophr Bull. 2022 May 7;48(3):575-589
pubmed: 35137235
J Interpers Violence. 2017 May;32(10):1543-1564
pubmed: 26112971
Psychol Med. 1996 Jul;26(4):775-83
pubmed: 8817712
Psychol Med. 2019 Jun;49(8):1378-1391
pubmed: 30282569
World Psychiatry. 2016 Jun;15(2):93-102
pubmed: 27265690
Int J Psychol. 2013;48(2):117-27
pubmed: 23597011
Br J Psychiatry. 2005 Aug;187:101-2
pubmed: 16055818
Child Abuse Negl. 2003 Feb;27(2):169-90
pubmed: 12615092
Brain Behav Immun. 2021 Jan;91:541-545
pubmed: 33166662
Schizophr Bull. 2011 May;37(3):546-53
pubmed: 19776204
Front Psychiatry. 2020 Mar 09;10:997
pubmed: 32210844
BMC Med Res Methodol. 2003 Oct 20;3:21
pubmed: 14567763
Child Abuse Negl. 2013 Jan;37(1):33-46
pubmed: 23317921
Schizophr Res Cogn. 2020 Oct 23;23:100189
pubmed: 33134093
Schizophr Bull. 2012 Jun;38(4):661-71
pubmed: 22461484
Int J Public Health. 2019 Mar;64(2):241-251
pubmed: 30506365
Int J Psychol. 2013;48(2):95-107
pubmed: 23597009
Health Aff (Millwood). 2005 Mar-Apr;24(2):343-52
pubmed: 15757918
Soc Psychiatry Psychiatr Epidemiol. 2020 May;55(5):645-657
pubmed: 31974809
Child Maltreat. 2011 Feb;16(1):63-73
pubmed: 21041234
BMJ Open. 2013 Aug 01;3(8):
pubmed: 23906948
Schizophr Bull. 2012 Jun;38(4):672-5
pubmed: 22837349
Psychol Bull. 1993 Jan;113(1):82-98
pubmed: 8426875
Psychol Med. 2021 Mar 02;:1-9
pubmed: 33648622
J Affect Disord. 2019 Sep 1;256:448-457
pubmed: 31252238
Neuroimage. 2014 Aug 15;97:236-44
pubmed: 24736182
Psychol Med. 2021 Jul;51(9):1536-1548
pubmed: 32122439
Bioinformatics. 2012 Jan 1;28(1):112-8
pubmed: 22039212
Int J Epidemiol. 2014 Jun;43(3):962-70
pubmed: 24603316
BMC Public Health. 2018 Oct 10;18(1):1164
pubmed: 30305071
BMC Psychiatry. 2019 Dec 27;19(1):418
pubmed: 31882002
World Psychiatry. 2021 Oct;20(3):417-436
pubmed: 34505386
Int J Epidemiol. 2018 Jun 1;47(3):780-787
pubmed: 29390062
Psychol Med. 2022 Oct;52(14):2972-2984
pubmed: 33563347
Psychol Med. 2000 May;30(3):529-44
pubmed: 10883709
BMC Med Res Methodol. 2008 Dec 16;8:80
pubmed: 19087281
Psychol Med. 2020 Jan;50(2):303-313
pubmed: 30722795
Br J Psychiatry. 2020 Oct;217(4):575-582
pubmed: 32778182
Annu Rev Public Health. 2008;29:235-52
pubmed: 18031225
Child Abuse Negl. 2015 Mar;41:30-9
pubmed: 25169149
Am J Med. 1999 Oct;107(4):332-9
pubmed: 10527034
Healthcare (Basel). 2021 Aug 30;9(9):
pubmed: 34574904
Child Abuse Negl. 2020 May;103:104439
pubmed: 32126398
Psychol Med. 2023 Apr;53(5):1970-1978
pubmed: 37310339
Lancet. 2005 Apr 9-15;365(9467):1309-14
pubmed: 15823380
Psychol Med. 2022 May;52(7):1376-1385
pubmed: 32958094
Am J Public Health. 2010 Apr 1;100 Suppl 1:S186-96
pubmed: 20147693
Lancet Psychiatry. 2019 May;6(5):427-436
pubmed: 30902669
World Psychiatry. 2019 Oct;18(3):247-258
pubmed: 31496097
Mol Psychiatry. 2022 Aug;27(8):3510-3519
pubmed: 35484237
Br J Psychiatry. 2009 Dec;195(6):488-91
pubmed: 19949195

Auteurs

Giuseppe D'Andrea (G)

Department of Medical and Surgical Sciences, Bologna Transcultural Psychosomatic Team (BoTPT), University of Bologna, Bologna, Italy.
Community Mental Health Center of Sassuolo, Department of Mental Health and Drug Abuse, AUSL Modena, Modena, Italy.

Jatin Lal (J)

Department of Medical and Surgical Sciences, Bologna Transcultural Psychosomatic Team (BoTPT), University of Bologna, Bologna, Italy.

Sarah Tosato (S)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.

Charlotte Gayer-Anderson (C)

ESRC Center for Society and Mental Health, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.

Hannah E Jongsma (HE)

Centre for Transcultural Psychiatry 'Veldzicht', Balkbrug, The Netherlands.
University Centre for Psychiatry, University Medical Centre Groningen, Groningen, The Netherlands.

Simona A Stilo (SA)

Department of Mental Health and Addiction Services, ASP Crotone, Crotone, Italy.
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Els van der Ven (E)

Department of Clinical, Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Diego Quattrone (D)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK.

Eva Velthorst (E)

Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA.

Domenico Berardi (D)

Department of Biomedical and Neuromotor Sciences (DIBINEM), Section of Psychiatry, University of Bologna, Bologna, Italy.

Paulo Rossi Menezes (P)

University Hospital, Section of Epidemiology, University of São Paulo, São Paulo, Brazil.

Celso Arango (C)

Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, CIBERSAM, Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.

Mara Parellada (M)

Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, CIBERSAM, Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.

Antonio Lasalvia (A)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.

Caterina La Cascia (C)

Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.

Laura Ferraro (L)

Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.

Daniele La Barbera (D)

Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.

Lucia Sideli (L)

Department of Human Science, LUMSA University, Rome, Italy.

Julio Bobes (J)

Department of Medicine, Psychiatry Area, School of Medicine, Universidad de Oviedo, ISPA, Ineuropa, CIBERSAM, Oviedo, Spain.

Miguel Bernardo (M)

Barcelona Clinic Schizophrenia Unit, Department of Medicine, Neuroscience Institute, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain.

Julio Sanjuán (J)

Department of Psychiatry, School of Medicine, Universidad de Valencia, Centro de Investigación Biomédica en Red de Salud Mental, Valencia, Spain.

Jose Luis Santos (JL)

Department of Psychiatry, Servicio de Psiquiatría Hospital "Virgen de la Luz", Cuenca, Spain.

Manuel Arrojo (M)

Department of Psychiatry, Psychiatric Genetic Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago, Spain.

Cristina Marta Del-Ben (CM)

Neuroscience and Behavior Department, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.

Giada Tripoli (G)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Piazza delle Cliniche, 290127 Palermo, Italy.

Pierre-Michel Llorca (PM)

Université Clermont Auvergne, EA 7280 Npsydo, Clermont-Ferrand, France.

Lieuwe de Haan (L)

Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands.

Jean-Paul Selten (JP)

School for Mental Health and Neuroscience, University of Maastricht, Maastricht, The Netherlands.

Andrea Tortelli (A)

Etablissement Public de Santé Maison Blanche, Paris, France.

Andrei Szöke (A)

Univ Paris Est Creteil, INSERM, IMRB, AP-HP, Hôpitaux Universitaires « H. Mondor », DMU IMPACT, Fondation Fondamental, F-94010 Créteil, France.

Roberto Muratori (R)

Department of Mental Health and Pathological Addiction, Local Health Authority, Bologna, Italy.

Bart P Rutten (BP)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.

Jim van Os (J)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.

Peter B Jones (PB)

Department of Psychiatry, University of Cambridge, Cambridge, UK.

James B Kirkbride (JB)

PsyLife Group, Division of Psychiatry, UCL, London, UK.

Robin M Murray (RM)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Marta di Forti (M)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK.

Ilaria Tarricone (I)

Department of Medical and Surgical Sciences, Bologna Transcultural Psychosomatic Team (BoTPT), University of Bologna, Bologna, Italy.
Department of Mental Health and Pathological Addiction, Local Health Authority, Bologna, Italy.

Craig Morgan (C)

ESRC Center for Society and Mental Health, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH